相似文献
1
Oxaliplatin-induced coronary artery spasm: first report of an important side-effect.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.06.2008.0334. Epub 2009 Feb 26.
2
Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation.
Cardiovasc Revasc Med. 2018 Dec;19(8S):13-15. doi: 10.1016/j.carrev.2018.06.019. Epub 2018 Jun 22.
3
Coronary artery spasm: use of ergonovine in diagnosis.
Aust N Z J Med. 1980 Feb;10(1):6-11. doi: 10.1111/j.1445-5994.1980.tb03410.x.
4
5
Coronary artery spasm after ingestion of Imodium (loperamide) in a 14-year-old boy.
Ann Pediatr Cardiol. 2016 May-Aug;9(2):158-60. doi: 10.4103/0974-2069.180669.
6
Zumba-induced Takotsubo cardiomyopathy: a case report.
J Med Case Rep. 2018 Jun 10;12(1):160. doi: 10.1186/s13256-018-1696-x.
7
Coronary artery spasm as the cause of myocardial infarction during coronary arteriogarphy.
Am Heart J. 1976 Apr;91(4):501-6. doi: 10.1016/s0002-8703(76)80333-x.
8
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer.
Ann Oncol. 2010 Jan;21(1):87-91. doi: 10.1093/annonc/mdp272. Epub 2009 Jul 21.
9
Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.
J Clin Oncol. 2007 Sep 20;25(27):4224-30. doi: 10.1200/JCO.2006.09.8467. Epub 2007 Jun 4.
10
Coronary artery spasm due to thyrotoxicosis.
N Z Med J. 2012 Jan 25;126(1368):75-8.
引用本文的文献
1
Oxaliplatin-Associated Takotsubo Cardiomyopathy in a Patient with Metastatic Gastric Cancer: A Case Report.
Case Rep Oncol. 2023 Aug 14;16(1):613-620. doi: 10.1159/000531389. eCollection 2023 Jan-Dec.
2
Case Report: Oxaliplatin-Induced Third-Degree Atrioventricular Block: First Discovery of an Important Side-Effect.
Front Cardiovasc Med. 2022 Jun 27;9:900406. doi: 10.3389/fcvm.2022.900406. eCollection 2022.
3
PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.
Pharm Res. 2013 Feb;30(2):412-23. doi: 10.1007/s11095-012-0883-5. Epub 2012 Sep 20.
本文引用的文献
1
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.
2
Cardiac sodium channel mutation in atrial fibrillation.
Heart Rhythm. 2008 Jan;5(1):99-105. doi: 10.1016/j.hrthm.2007.09.015. Epub 2007 Sep 19.
3
Oxaliplatin-related neurotoxicity: how and why?
Crit Rev Oncol Hematol. 2006 Aug;59(2):159-68. doi: 10.1016/j.critrevonc.2006.01.001. Epub 2006 Jun 27.
4
Cardiotoxicity of 5-fluorouracil.
Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. doi: 10.2174/187152506775268785.
5
Oxaliplatin-induced neurotoxicity and the development of neuropathy.
Muscle Nerve. 2005 Jul;32(1):51-60. doi: 10.1002/mus.20340.
6
XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
J Clin Oncol. 2004 Jun 1;22(11):2084-91. doi: 10.1200/JCO.2004.11.069.
7
Angina pectoris. I. A variant form of angina pectoris; preliminary report.
Am J Med. 1959 Sep;27:375-88. doi: 10.1016/0002-9343(59)90003-8.
8
[Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].
Ned Tijdschr Geneeskd. 2003 Mar 8;147(10):457-60.
9
Failure to find evidence for association between voltage-gated sodium channel gene SCN2A variants and febrile seizures in humans.
Neurosci Lett. 2002 Aug 30;329(2):249-51. doi: 10.1016/s0304-3940(02)00651-1.
10
Hürthle cell carcinoma: a critical histopathologic appraisal.
J Clin Oncol. 2001 May 15;19(10):2616-25. doi: 10.1200/JCO.2001.19.10.2616.
Zotero 插件